References
1. Garber JE, Offit K. Hereditary cancer predisposition syndromes.J Clin Oncol. 2005;23(2):276-292.
2. Schiffman JD. Hereditary cancer syndromes: if you look, you will find them. Pediatr Blood Cancer. 2012;58(1):5-6.
3. Zhang J, Walsh MF, Wu G, et al. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015;373(24):2336-2346.
4. Grobner SN, Worst BC, Weischenfeldt J, et al. The landscape of genomic alterations across childhood cancers. Nature.2018;555(7696):321-327.
5. Mody RJ, Wu YM, Lonigro RJ, et al. Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. JAMA.2015;314(9):913-925.
6. Oberg JA, Glade Bender JL, Sulis ML, et al. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations. Genome Med. 2016;8(1):133.
7. Chang W, Brohl AS, Patidar R, et al. MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research.Clin Cancer Res. 2016;22(15):3810-3820.
8. Kline CN, Joseph NM, Grenert JP, et al. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.Neuro Oncol. 2017;19(5):699-709.
9. Diets IJ, Waanders E, Ligtenberg MJ, et al. High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer. Clin Cancer Res.2018;24(7):1594-1603.
10. Parsons DW, Roy A, Yang Y, et al. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.JAMA Oncol. 2016;2(5):616-624.
11. Jongmans MC, Loeffen JL, Waanders E, et al. Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool. Eur J Med Genet. 2016;59(3):116-125.
12. Malkin D, Nichols KE, Schiffman JD, Plon SE, Brodeur GM. The Future of Surveillance in the Context of Cancer Predisposition: Through the Murky Looking Glass. Clin Cancer Res. 2017;23(21):e133-e137.
13. Villani A, Shore A, Wasserman JD, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.Lancet Oncol. 2016;17(9):1295-1305.
14. Ripperger T, Bielack SS, Borkhardt A, et al. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. Am J Med Genet A. 2017;173(4):1017-1037.
15. Druker H, Zelley K, McGee RB, et al. Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient. Clin Cancer Res.2017;23(13):e91-e97.
16. Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2018;68(4):297-316.
17. Hampel H, Bennett RL, Buchanan A, et al. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med. 2015;17(1):70-87.
18. Vig HS, Armstrong J, Egleston BL, et al. Cancer genetic risk assessment and referral patterns in primary care. Genet Test Mol Biomarkers. 2009;13(6):735-741.
19. Chen MJ, Holt CL, Lose EJ, Robin NH. The use by Alabama pediatricians of genetics consultation in the evaluation of developmental delay. Am J Med Genet A. 2008;146A(4):421-425.
20. Diamonstein C, Stevens B, Shahrukh Hashmi S, Refuerzo J, Sullivan C, Hoskovec J. Physicians’ Awareness and Utilization of Genetic Services in Texas. J Genet Couns. 2018;27(4):968-977.
21. Batra S, Valdimarsdottir H, McGovern M, Itzkowitz S, Brown K. Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol.2002;97(3):729-733.
22. Garcia C, Harrison K, Ring KL, Sullivan MW, Rauh LA, Modesitt SC. Genetic counseling referral for ovarian cancer patients: a call to action. Fam Cancer. 2019;18(3):303-309.
23. Carroll JC, Cappelli M, Miller F, et al. Genetic services for hereditary breast/ovarian and colorectal cancers - physicians’ awareness, use and satisfaction. Community Genet.2008;11(1):43-51.
24. Al-Habsi H, Lim JN, Chu CE, Hewison J. Factors influencing the referrals in primary care of asymptomatic patients with a family history of cancer. Genet Med. 2008;10(10):751-757.
25. Acheson LS, Stange KC, Zyzanski S. Clinical genetics issues encountered by family physicians. Genet Med. 2005;7(7):501-508.
26. Brandt R, Ali Z, Sabel A, McHugh T, Gilman P. Cancer genetics evaluation: barriers to and improvements for referral. Genet Test. 2008;12(1):9-12.
27. Liang MI, Wong DH, Walsh CS, Farias-Eisner R, Cohen JG. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers. J Genet Couns. 2018;27(1):177-186.
28. Mirabello L, Zhu B, Koster R, et al. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. JAMA Oncol. 2020.
29. Bathurst L, Huang QR. A qualitative study of GPs’ views on modern genetics. Aust Fam Physician. 2006;35(6):462-464.
30. Saul RA, Trotter T, Sease K, Tarini B. Survey of family history taking and genetic testing in pediatric practice. J Community Genet. 2017;8(2):109-115.
31. Rinke ML, Mikat-Stevens N, Saul R, Driscoll A, Healy J, Tarini BA. Genetic services and attitudes in primary care pediatrics. Am J Med Genet A. 2014;164A(2):449-455.
32. Acheson LS, Wiesner GL, Zyzanski SJ, Goodwin MA, Stange KC. Family history-taking in community family practice: implications for genetic screening. Genet Med. 2000;2(3):180-185.
33. Wood ME, Stockdale A, Flynn BS. Interviews with primary care physicians regarding taking and interpreting the cancer family history.Fam Pract. 2008;25(5):334-340.
34. Lu KH, Wood ME, Daniels M, et al. American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol. 2014;32(8):833-840.
35. Febbraro T, Robison K, Wilbur JS, et al. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals. Gynecol Oncol. 2015;138(1):109-114.
36. Knapke S, Nagarajan R, Correll J, Kent D, Burns K. Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatr Blood Cancer. 2012;58(1):85-89.
37. Russo S, Warby M, Tucker KM, Wakefield CE, Cohn RJ. Importance of updating family cancer history in childhood cancer survivors. Fam Cancer. 2017;16(4):605-610.
38. Rolnick SJ, Rahm AK, Jackson JM, et al. Barriers in identification and referral to genetic counseling for familial cancer risk: the perspective of genetic service providers. J Genet Couns.2011;20(3):314-322.
39. Kentwell M, Dow E, Antill Y, et al. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics. Gynecol Oncol. 2017;145(1):130-136.
40. Senter L, O’Malley DM, Backes FJ, et al. Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care. Gynecol Oncol. 2017;147(1):110-114.
41. Kuhlen M, Wieczorek D, Siebert R, Fruhwald MC. How I approach hereditary cancer predisposition in a child with cancer. Pediatr Blood Cancer. 2019;66(11):e27916.
42. Prochniak CF, Martin LJ, Miller EM, Knapke SC. Barriers to and motivations for physician referral of patients to cancer genetics clinics. J Genet Couns. 2012;21(2):305-325.
43. Houwink EJ, van Luijk SJ, Henneman L, van der Vleuten C, Jan Dinant G, Cornel MC. Genetic educational needs and the role of genetics in primary care: a focus group study with multiple perspectives. BMC Fam Pract. 2011;12:5.
44. Cooksey JA, Forte G, Benkendorf J, Blitzer MG. The state of the medical geneticist workforce: findings of the 2003 survey of American Board of Medical Genetics certified geneticists. Genet Med.2005;7(6):439-443.
45. Hoskovec JM, Bennett RL, Carey ME, et al. Projecting the Supply and Demand for Certified Genetic Counselors: a Workforce Study. J Genet Couns. 2018;27(1):16-20.
46. Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol.2004;2(9):813-819.
47. Tsang S, Royse CF, Terkawi AS. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi J Anaesth. 2017;11(Suppl 1):S80-S89.
48. Prete FP, Abdel-Aziz T, Morkane C, Brain C, Kurzawinski TR, Group MENiCUC. Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. Br J Surg. 2018;105(10):1319-1327.